CIMB Securities analysis: POH Outperform, target $0.27.
Must have been comparing notes with Morgans.
Recommendation made after announcement of the mastitis trials in US.
Maybe they'll update the target price following the positive AGM news.
rbs morgans weekly research report, page-14
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 36084472 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 35403846 | 21 |
View Market Depth
| Last trade - 16.12pm 11/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable